The previous AD/PD™ meeting showcased cutting-edge research spanning novel disease mechanisms, biomarkers, and therapeutic strategies. Hundreds of oral presentations and posters highlighted the rapid progress being made across Alzheimer’s, Parkinson’s, and overlapping neurodegenerative conditions.